Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-PHENO-24540

Xla Wt + Hsa.krasV12 : GFP, Moruzzi M et al. (2021)

Experiment + Assay: Xla Wt + Hsa.krasV12 : GFP + NF10 (immunohistochemistry)
Background: Xla.Inbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
mRNA injection Tg(Hsa.krasV12 : GFP) krasl (Xla)
 NF stage 6 (32-cell) blastomere
Conditions:
Assay Type Assay Stages Antibody
immunohistochemistry NF stage 10 to NF stage 10  
Anatomical Phenotypes: abnormal epithelium morphology, abnormally localised epithelial cell
Human Disease Associations: carcinoma
Source: Fig. S 1 F G
Article: XB-ART-58186, PubMed